FDA-Drug2026-10-21Class IIPROCESSING DEFECT
Houston Rx LLC Sermorelin injectable recalled for lack of manufacturing process control
What this means
Houston Rx LLC is recalling one lot of Sermorelin 1 mg/mL injectable solution due to inadequate process controls during manufacturing. This affects 7 vials with lot number SER-081726-1-10 and a beyond-use date of 10/01/2026, distributed nationwide. No injuries have been reported.
- If you have this medication, contact your prescriber or pharmacist for guidance.
- Do not use the recalled lot number SER-081726-1-10.
The agency's original wording
Hazard
Lack of process control
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide in the USA.
Affected count
7 vials
Manufactured in
15340 Vantage Pkwy E Ste 220, Houston, TX, United States
Products
Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0041-2027More Houston Rx recalls
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.